U.S. flag

An official website of the United States government

NM_000249.4(MLH1):c.-93G>A AND Colorectal cancer, hereditary nonpolyposis, type 2

Germline classification:
Benign (2 submissions)
Last evaluated:
Mar 6, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000018636.43

Allele description [Variation Report for NM_000249.4(MLH1):c.-93G>A]

NM_000249.4(MLH1):c.-93G>A

Gene:
MLH1:mutL homolog 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p22.2
Genomic location:
Preferred name:
NM_000249.4(MLH1):c.-93G>A
Other names:
MLH1, EPIGENETICALLY SILENCED INHERITED, PROMOTER
HGVS:
  • NC_000003.12:g.36993455G>A
  • NG_007109.2:g.5106G>A
  • NG_008418.1:g.4850C>T
  • NM_000249.3:c.-93G>A
  • NM_001167617.2:c.-609G>A
  • NM_001167618.2:c.-1038G>A
  • NM_001167619.2:c.-951G>A
  • NM_001258271.1:c.-93G>A
  • NM_001258273.1:c.-725G>A
  • NM_001258274.2:c.-1188G>A
  • NM_001354615.1:c.-719G>A
  • NM_001354616.1:c.-719G>A
  • NM_001354617.1:c.-811G>A
  • NM_001354618.1:c.-1043G>A
  • NM_001354619.1:c.-1167G>A
  • NM_001354620.1:c.-377G>A
  • NM_001354621.1:c.-1136G>A
  • NM_001354622.1:c.-1249G>A
  • NM_001354623.1:c.-1158G>A
  • NM_001354624.1:c.-919G>A
  • NM_001354625.1:c.-817G>A
  • NM_001354626.1:c.-914G>A
  • NM_001354627.1:c.-1146G>A
  • NM_001354628.1:c.-93G>A
  • NM_001354629.1:c.-93G>A
  • NM_001354630.1:c.-93G>A
  • LRG_216t1:c.-93G>A
  • LRG_216:g.5106G>A
  • NC_000003.11:g.37034946G>A
  • NM_000249.4:c.-93G>AMANE SELECT
Links:
OMIM: 120436.0026; dbSNP: rs1800734
NCBI 1000 Genomes Browser:
rs1800734

Condition(s)

Name:
Colorectal cancer, hereditary nonpolyposis, type 2 (LYNCH2)
Synonyms:
COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 2; Lynch syndrome II; MLH1-Related Lynch Syndrome; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0012249; MedGen: C1333991; Orphanet: 144; OMIM: 609310

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000038919OMIM
no assertion criteria provided
Uncertain significance
(Feb 15, 2007)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Hamosh, A. Personal Communication. 2018. Baltimore, Md.,

SCV000443321Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification Criteria 13 December 2019)
Benign
(Mar 6, 2018)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Inheritance of a cancer-associated MLH1 germ-line epimutation.

Hitchins MP, Wong JJ, Suthers G, Suter CM, Martin DI, Hawkins NJ, Ward RL.

N Engl J Med. 2007 Feb 15;356(7):697-705.

PubMed [citation]
PMID:
17301300

Details of each submission

From OMIM, SCV000038919.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

This variant, formerly titled COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2, has been reclassified based on a review of the dbSNP and 1000 Genomes Project databases by Hamosh (2018).

Hitchins et al. (2007) described a family in which a 66-year-old woman, the mother of 3 sons by 2 different men, had the clinical picture of hereditary nonpolyposis colorectal cancer (see LYNCH2, 609310). She had metachronous carcinomas that had microsatellite instability and lacked MLH1 expression. The diagnosis of cancer of the endometrium was made at the age of 45; of the colon at age 59; and of the rectum at 60 years. She was heterozygous for a SNP within the MLH1 promoter (rs1800734), with methylation confined to the A allele. In this woman methylation of the A allele on approximately 50% of chromosomes was confirmed by sulfite sequencing. Hitchins et al. (2007) identified an expressible C-T SNP within MLH1 exon 16 in her son, which was used to demonstrate that he was transcribing RNA only from the MLH1 allele inherited from his father. The data were consistent with transmission of the MLH1 epimutation from the proband to her son. In DNA from peripheral blood leukocytes obtained from this son, approximately half of the MLH1 alleles were methylated. In contrast, his sperm had no trace of MLH1 methylation, despite containing equal proportions of alleles derived from his father and mother. Furthermore, analysis of the RNA in his sperm at the MLH1 exon 16 C-T SNP showed reactivation of the maternally derived MLH1 allele. These results indicated reversion of the MLH1 epimutation to normality during spermatogenesis, suggesting a negligible risk of transmission from that family member.

Hamosh (2018) found that the c.-93G-A (NM_000249.3) MLH1 promoter variant was present at a minor allele frequency (MAF) of 0.32 in dbSNP and in 552 of 1,008 East Asian alleles (MAF 55%) in the 1000 Genomes Project database (April 20, 2018), suggesting that the variant is not pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Illumina Laboratory Services, Illumina, SCV000443321.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024